IL31RA and neoplasm: Given that neddylation and CRL inhibitors emerge as an area of very active research in the field of tumor drug development, it is tempting to speculate that upcoming compounds that target neddylation or CRL activity could be repurposed and applied as antiviral drugs against cytomegaloviruses.